Theory of Mind in Parkinson's Disease and Related Basal Ganglia Disorders: A Systematic ReviewBODDEN, Maren Elisabeth; DODEL, Richard; KALBE, Elke et al.Movement disorders. 2010, Vol 25, Num 1, pp 13-27, issn 0885-3185, 15 p.Article

Health-related quality of life and healthcare utilisation in patients with Parkinson's disease: Impact of motor fluctuations and dyskinesiasDODEL, Richard C; BERGER, Karin; OERTEL, Wolfgang H et al.PharmacoEconomics (Auckland). 2001, Vol 19, Num 10, pp 1013-1038, issn 1170-7690Article

APP transgenic mice: The effect of active and passive immunotherapy in cognitive tasksRÖSKAM, Stephan; NEFF, Frauke; SCHWARTING, Rainer et al.Neuroscience and biobehavioral reviews. 2010, Vol 34, Num 4, pp 487-499, issn 0149-7634, 13 p.Article

Comparative Responsiveness of Parkinson's Disease Scales to Change Over TimeSCHRAG, Anette; SPOTTKE, Annika; QUINN, Niall Patrick et al.Movement disorders. 2009, Vol 24, Num 6, pp 813-818, issn 0885-3185, 6 p.Article

Economic Evaluation of Treatment Options in Patients with Alzheimer's Disease: A Systematic Review of Cost-Effectiveness AnalysesPOURYAMOUT, Laura; DAMS, Judith; WASEM, Juergen et al.Drugs (Basel). 2012, Vol 72, Num 6, pp 789-802, issn 0012-6667, 14 p.Article

Cost of Epilepsy : A Systematic ReviewSTRZELCZYK, Adam; REESE, Jens Peter; DODEL, Richard et al.PharmacoEconomics (Auckland). 2008, Vol 26, Num 6, pp 463-476, issn 1170-7690, 14 p.Article

Copper deficiency associated with severe neurological disorder — A genetic work-up of possible mutations in copper transport proteinsBACH, Jan-Philipp; KUMAR, Neeraj; DEPBOYLU, Candan et al.Journal of the neurological sciences. 2010, Vol 291, Num 1-2, pp 95-97, issn 0022-510X, 3 p.Article

Lewy body dementia and Parkinson's disease with dementiaDODEL, Richard; CSOTI, Ilona; EBERSBACH, Georg et al.Journal of neurology. Supplement. 2008, Vol 255, Num 5, pp 39-47, issn 0939-1517, 9 p.Article

The flavanoide caffeic acid phenethyl ester blocks 6-hydroxydopamine-induced neurotoxicityNOELKER, Carmen; BACHER, Michael; GOCKE, Petra et al.Neuroscience letters. 2005, Vol 383, Num 1-2, pp 39-43, issn 0304-3940, 5 p.Article

The socioeconomic impact of narcolepsyDODEL, Richard; PETER, Helga; MAYER, Geert et al.Sleep (New York, NY). 2004, Vol 27, Num 6, pp 1123-1128, issn 0161-8105, 6 p.Article

Human antibodies against amyloid β peptide: A potential treatment for Alzheimer's diseaseDODEL, Richard; HAMPEL, Harald; HEMMER, Bernhard et al.Annals of neurology. 2002, Vol 52, Num 2, pp 253-256, issn 0364-5134Article

Incidence of Parkinson's Disease and Atypical Parkinsonism: Russian Population-Based StudyWINTER, Yaroslav; BEZDOLNYY, Yury; KATUNINA, Elena et al.Movement disorders. 2010, Vol 25, Num 3, pp 349-356, issn 0885-3185, 8 p.Article

Macrophage Migration Inhibitory Factor in Normal Human Skeletal Muscle and Inflammatory MyopathiesREIMANN, Jens; SCHNELL, Susanne; SCHWARTZ, Stephanie et al.Journal of neuropathology and experimental neurology. 2010, Vol 69, Num 6, pp 654-662, issn 0022-3069, 9 p.Article

Costs of Illness in a Russian Cohort of Patients with Parkinson's DiseaseWINTER, Yaroslav; VON CAMPENHAUSEN, Sonja; POPOV, Georgy et al.PharmacoEconomics (Auckland). 2009, Vol 27, Num 7, pp 571-584, issn 1170-7690, 14 p.Article

Peripheral and central biodistribution of ¹¹¹In-labeled anti-beta-amyloid autoantibodies in a transgenic mouse model of Alzheimer's diseaseBACHER, Michael; DEPBOYLU, Candan; YANSHENG DU et al.Neuroscience letters. 2009, Vol 449, Num 3, pp 240-245, issn 0304-3940, 6 p.Article

Cognitive impairment in 873 patients with idiopathic Parkinson's disease : Results from the German Study on Epidemiology of Parkinson's Disease with Dementia (GEPAD)RIEDEL, Oliver; KLOTSCHE, Jens; TRENKWALDER, Claudia et al.Journal of neurology. 2008, Vol 255, Num 2, pp 255-264, issn 0340-5354, 10 p.Article

Cost Effectiveness of Pharmacotherapies in Early Parkinson's DiseaseEGGERT, Karla M; REESE, Jens P; OERTEL, Wolfgang H et al.CNS drugs. 2008, Vol 22, Num 10, pp 841-860, issn 1172-7047, 20 p.Article

Movement disorder society-sponsored revision of the unified Parkinson's disease rating scale (MDS-UPDRS) : Process, format, and clinimetric testing planGOETZ, Christopher G; FAHN, Stanley; HOLLOWAY, Robert et al.Movement disorders. 2007, Vol 22, Num 1, pp 41-47, issn 0885-3185, 7 p.Article

Rate of clinical progression in parkinson's disease. A prospective studySCHRAG, Anette; DODEL, Richard; SPOTTKE, Annika et al.Movement disorders. 2007, Vol 22, Num 7, pp 938-945, issn 0885-3185, 8 p.Article

Impact of complications and comorbidities on treatment costs and health-related quality of life of patients with Parkinson's diseaseBACH, Jan-Philipp; RIEDEL, Oliver; KLOTSCHE, Jens et al.Journal of the neurological sciences. 2012, Vol 314, Num 1-2, pp 41-47, issn 0022-510X, 7 p.Article

Cost of illness in patients with Gilles de la Tourette's syndromeDODEL, Ines; REESE, Jens Peter; MÜLLER, Norbert et al.Journal of neurology. 2010, Vol 257, Num 7, pp 1055-1061, issn 0340-5354, 7 p.Article

Health Economic Burden of Patients with Restless Legs Syndrome in a German Ambulatory SettingDODEL, Richard; HAPPE, Svenja; STIASNY-KOLSTER, Karin et al.PharmacoEconomics (Auckland). 2010, Vol 28, Num 5, pp 381-393, issn 1170-7690, 13 p.Article

Safety and Efficacy of Perampanel in Advanced Parkinson's Disease: A Randomized, Placebo-Controlled StudyEGGERT, Karla; SQUILLACOTE, David; TRENKWALDER, Claudia et al.Movement disorders. 2010, Vol 25, Num 7, pp 896-905, issn 0885-3185, 10 p.Article

Evaluation of costs and outcome in cardioembolic stroke or TIAWINTER, Yaroslav; WOLFRAM, Caroline; SCHAEG, Matthias et al.Journal of neurology. 2009, Vol 256, Num 6, pp 954-963, issn 0340-5354, 10 p.Article

Cost of illness and its predictors for Parkinson's disease in GermanySPOTTKE, Annika E; REUTER, Martin; SIEBERT, Uwe et al.PharmacoEconomics (Auckland). 2005, Vol 23, Num 8, pp 817-836, issn 1170-7690, 20 p.Article